News


August 2025

Arnold Johnson has joined the group as a postdoc. Welcome, Arnold!

Dr. Yingye Zheng presented a new modeling framework for designing biomarker utility trials at JSM2025. Her talk, "Raising the Bar for Launching Biomarker Utility Trial Design with Muti-stage Incidence and Mortality Modeling," explored how to link test performance to cancer mortality outcomes using real-world implementation pathways.
 

Yingqi Zhao (Chair and Organizer) and Yingye Zheng (Organizer) lead an invited session at JSM 2025 titled "Pioneering New Strategies in Preventive Healthcare: Design and Analysis Innovations."


June 2025

Dr. Yingye Zheng gave a talk, "Raising the Bar for Launching Screening Trials — Which Criteria Should be Satisfied?" at the 2025 International Cancer Screening Network conference in Aarhus, Denmark. 

Dr. Zheng presenting a slide show

May 2025

Dr. Yingye Zheng had a poster presentation at the 14th EDRN Scientific Workshop.


April 2025

Dr. Yingqi Zhao visited the Department of Biostatistics at MD Anderson Cancer Center, and presented work on design for cancer screening trials: Addressing Real-world Challenges in Cancer Early Detection and Therapeutic Studies



November 2024

FHCC's Science Spotlight series featured a new Biometrics paper by Kehao Zhu, Yingqi Zhao and Yingye Zheng. The paper features a new approach to cancer screenign trial design. The paper can be found here. Congratulations!


September 2024

Patient-Centered Outcomes Research Institute (PCORI) awards Yingqi Zhao Research GrantThe 3-year award was in response to PCORI's "Improving Methods for Conducting Patient-Centered Outcomes Research" funding announcement. The study aims to develop and improve the design and analysis of randomized screening trials (RSTs) for early cancer detection. The ultimate objective is to enable more efficient and accurate trials that assess the mortality benefits of cancer screening, while also considering the potential harms, to guide informed decision-making for screening practices.